Electronic medical records (EMRs) are the software programs that underlie internal clinic workflow at most health care organizations. They’ve been around for a while but implementation nearly doubled nationwide from 2007 to 2012, thanks to the federal resources poured...
EHR
Meaningful Use: What to Expect
Last month, acting CMS administrator Andy Slavitt kicked up a media speculation storm when he said,“We are now in the process of ending Meaningful Use and moving to a new regime culminating with the MACRA implementation. The Meaningful Use program as it has existed...
Meaningful Use, One Step Closer to Finalization
The rules for Stage 3 meaningful use, and the potential modifications to Stage 2, moved one step closer to finalization last week when The Centers for Medicare & Medicaid Services (CMS) handed them off to the Office of Management and Budget (OMB) on September 3rd....
Navigating Cancer’s Official Comments on Stage 3 Meaningful Use Proposed Rule
To: Centers for Medicare & Medicaid Services Date: May 28, 2015 Re.: Comments on the Centers for Medicare Medicaid Services (CMS) Proposed Rule: Electronic Health Record Incentive Program Stage 3. Navigating Cancer, Inc. appreciates this opportunity to...
How to Create a Meaningful Experience for Your Patients on the Portal
Many healthcare professionals (HCPs) have made tremendous headway in incorporating electronic health records (EHRs) and patient portals into their practices to meet meaningful use requirements and facilitate patient engagement. Many patients also have been using...
New Research on Patient Portals: Is Your EMR the Safest Choice?
There is a lot of news lately on the adoption of patient portals. And for good reason, the deadline for adopting and using a patient portal to meet Stage 2 Meaningful Use requirements is 2014, which is quickly approaching. Patient portal adoption and active use is...
Search
Stay in the Know
The Navigating Cancer weekly email newsletter keeps you up to date on all the latest innovations and best practices in oncology care.